Search - tctmd.com

Displaying 1 - 20 of 87

Sort: Relevancy | Date

New Valvuloplasty Devices III: Bard TRUE and TRUE-Flow Balloon Valvuloplasty - Technical Advantages and Clinical Applications

Presentation TCT 2016

New Valvuloplasty Devices III: Bard TRUE and TRUE-Flow Balloon Valvuloplasty - Technical Advantages and Clinical Applications

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Cheng-Han Chen

November 01, 2016

New Valvuloplasty Devices II: InterValve V8 Balloon Valvuloplasty - Technical Advantages and Clinical Applications

Presentation TCT 2016

New Valvuloplasty Devices II: InterValve V8 Balloon Valvuloplasty - Technical Advantages and Clinical Applications

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Wesley R. Pedersen

November 01, 2016

Spectrum and Assessment of TAVR Accessory Devices (Valvuloplasty Balloons, Neuroprotection Systems, and More)

Presentation TCT 2016

Spectrum and Assessment of TAVR Accessory Devices (Valvuloplasty Balloons, Neuroprotection Systems, and More)

Presenter: Nicole Ibrahim, Martin B. Leon

November 01, 2016

TCT 1540: Successful PCI for Acute LAD Occlusion Due to Balloon Rupture Following Aortic Valvuloplasty

Presentation TCT 2016

TCT 1540: Successful PCI for Acute LAD Occlusion Due to Balloon Rupture Following Aortic Valvuloplasty

Presenter: Jean-Claude Laborde, Thomas Walther, Jalal Zamani

October 31, 2016

TCT 81: Clinical and Hemodynamic Results After Direct Transcatheter Aortic Valve Replacement Versus Pre-Implantation Balloon Aortic Valvuloplasty. A Case-Matched Analysis

Presentation TCT 2016

TCT 81: Clinical and Hemodynamic Results After Direct Transcatheter Aortic Valve Replacement Versus Pre-Implantation Balloon Aortic Valvuloplasty. A Case-Matched Analysis

Presenter: Mayra Guerrero, Roger J. Laham, Luis Nombela-Franco

October 31, 2016

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

September 13, 2016

News Daily News

Mortality Risk High in TAVR Patients Who Require Mechanical Circulatory Support

August 25, 2016

News Industry News

Essential Medical Inc. Announces CE Mark Approval for the MANTA™ Large Bore Vascular Closure Device

July 18, 2016

News Daily News

Combining Off-Pump CABG and Transaortic TAVR May Be an Option in Some Cases

July 14, 2016

News Industry News

Essential Medical Inc. Announces FDA Approval to Begin a U.S. Clinical Trial for the MANTA™ Large Bore Vascular Closure Device

July 08, 2016

News Daily News

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Michael O'Riordan

July 05, 2016

News Features

Clots Found in the Left Atrial Appendage: A Big Deal for TAVR?

June 27, 2016

News Conference News TVT 2016

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Michael O'Riordan

June 20, 2016

STATE-OF-THE-ART LECTURE: Balloon Aortic Valvuloplasty in 2016 Equipment, Optimal Procedural Techniques, and Clinical Outcomes

Presentation TVT 2016

STATE-OF-THE-ART LECTURE: Balloon Aortic Valvuloplasty in 2016 Equipment, Optimal Procedural Techniques, and Clinical Outcomes

Presenter: Helene Eltchaninoff

June 17, 2016

News Daily News

Predilatation or No Predilatation in TAVR? European Series Offers Reassurances Both Ways

Michael O'Riordan

May 02, 2016

News Industry News

Essential Medical Inc. Announces Successful Completion of EU Clinical Studies for MANTA™ Large Bore Vascular Closure Device

January 31, 2016

News Industry News

Medeon Biodesign Announces Successful First-in-man Studies for Large Bore Vascular Closure Device

November 02, 2015

News Conference News TCT 2015

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

October 12, 2015

News Daily News

若 TAVR 前不行瓣膜成形术，则脑栓塞更严重

September 21, 2015

News Daily News

Mayor Embolización Cerebral Cuando Antes de la TAVR No se realiza una Valvuloplastia

September 21, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.